Company intelligence / Profile preview

BIOPHEX

Munich, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

Biopharmaceutical Excellence (BioPhex) is a specialized strategic consultancy focused on the development and commercialization of advanced therapy medicinal products (ATMPs), including cell and gene therapies. The company provides expert guidance on regulatory strategy, clinical development, and market access to biotech and pharmaceutical firms worldwide. BioPhex leverages deep scientific and industry expertise to help clients navigate the complex landscape of biologics and innovative medicines. In 2019, the company was acquired by PharmaLex, a leading global provider of specialized services for the pharma, biotech, and medical device industries, where it continues to operate as a specialized brand.

Industry: Consulting

Beyond the preview

Go deeper on BIOPHEX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIOPHEX.

Explore the full profile